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Abstract: The investigation of clandestine laboratories poses serious hazards for first responders,
emergency services, investigators and the surrounding public due to the risk of exposure to volatile
organic compounds (VOCs) used in the manufacture of illicit substances. A novel gas sampling
interface using open microfluidic channels that enables the extraction of VOCs out of the gas phase
and into a liquid, where it can be analysed by conventional detection systems, has recently been
developed. This paper investigates the efficiency and effectiveness of such a gas-to-liquid (GTL)
extraction system for the extraction of amphetamine-type substances (ATS) and their precursors
from the vapour phase. The GTL interface was evaluated across a range of different ATS and their
precursors (methamphetamine, dimethylamphetamine, N-formylmethamphetamine, benzaldehyde,
phenyl-2-propanone, ephedrine and pseudoephedrine) at concentrations ranging between 10 and
32 mg m−3. These gas samples were produced by a gas generation system directly in Tedlar® bags
and gas canisters for controlled volume sampling. When using gas sampled from Tedlar® bags,
four of the seven compounds were able to be extracted by the GTL interface, with the majority of
the VOCs having extraction yields between 0.005% and 4.5%, in line with the results from an initial
study. When samples were taken from gas canisters, only benzaldehyde was able to be detected,
with extraction efficiencies between 0.2% and 0.4%. A custom-built mount for the GTL interface
helped to automate the extraction process, with the aim of increasing extraction efficiency or reducing
variability. However, the extraction efficiency did not improve when using this accessory, but the
procedure did become more efficient. The results from the study indicated that the GTL interface
could be employed for the collection of gaseous ATS and incorporated into mobile detection systems
for onsite collection and analysis of volatile compounds related to ATS manufacture.
Keywords: gas-to-liquid extraction; amphetamine; VOC; microfluidic; drug screening
1. Introduction
Over the 2015–2016 financial year, Australian law enforcement agencies identified 575
clandestine amphetamine-type substances (ATS) laboratories [1]. ATS manufacture (including
3,4-methylenedioxymethylamphetamine (MDMA)) and pseudoephedrine extraction facilities
accounted for 63.6% of all clandestine laboratory detections [1]. The route of synthesis was found to
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vary by state, with the majority of New South Wales laboratories favouring the hypophosphorous
method, Queensland laboratories favouring red phosphorus, and Western Australia laboratories
generally using the Nazi–Birch method. The Australian Criminal Intelligence Commission (ACIC)
report also found that 68.5% of all laboratories were located in residential areas [1].
In conjunction with a myriad of potential hazards associated with investigating clandestine
laboratories, their common occurrence in residential areas poses a health risk to the general
public, who may come into contact with toxic compounds and chemical waste associated with
ATS synthesis [2,3]. Clandestine laboratory investigation is also becoming more challenging with
operators in different states preferring different manufacturing methods, preventing investigators
from using a single targeted approach to response, investigation, and remediation. The occurrence of
different synthetic methods raises significant health concerns for investigators, and first responders
as potential hazards may be unknown, with possible exposure to toxic volatile organic compounds
(VOCs) [4]. In the synthesis of methamphetamine (MA) from ephedrine/pseudoephedrine via complex
iodine/phosphorus methods, for example, iodine, acids, phosphine and various toxic by-products have
been identified [5,6]. Vapour concentrations for MA, iodine and hydrochloric acid have been detected
at ranges between 0.01 and 5 mg m−3 [7].
Given potential hazards at clandestine laboratories, there is a need for the portable contactless
screening and identification of hazardous VOCs [8–10]. The onsite detection of hazardous VOCs
can assist in hazard mitigation for investigators and the public, as well as providing rapid onsite
forensic intelligence to help progress investigations. One of the most common air sampling techniques
is solid-phase microextraction (SPME), which has been well-documented for the analysis of a wide
range of ATS as well as other illicit compounds that may be present at clandestine laboratories, such
as cannabinoids, cocaine and cathinones [11–14]. Investigators in New Zealand have developed a
dynamic SPME method for onsite sample collection at former clandestine laboratory sites. By encasing
an SPME fibre in a stainless-steel tube and applying a vacuum to one end, they developed a dynamic
SPME technique that allows for large volumes of air to pass over the fibre’s adsorbent coating. The fibre
was then taken back to the laboratory for conventional gas chromatography mass spectrometry (GCMS)
analysis. By using this sampling and analysis methodology, they were able to detect airborne MA
in 5–20 min in areas, where swabs showed concentrations greater than 0.04 µg m−2 [15]. Capillary
microextraction (CME) has also been researched as a viable method of volatile ATS detection. The CME
technique consisted of PDMS-coated glass filter strips inside a glass tube that were used dynamically
to detect ATS vapour in areas, where the vapour concentration ranged between 0.4 and 4.2 µg m−3.
The CME analysed by GCMS fitted with a thermal desorption unit produced good reproducibility
and was found to be approximately 30 times more sensitive than the dynamic SPME method [16].
Similar in principle to SPME, scent transfer units have also been developed that combine a vacuum
mounted behind an absorbent gauze pad that draws large volumes of air through the pad, which can
then be stored, thermally desorbed and analysed by standard forensic techniques [17]. Field-portable
MS systems have also been investigated for their possible applications in a range of tasks surrounding
clandestine laboratory investigation. Using an atmospheric-pressure chemical-ionisation MS system
and a selective target mass fragment filter, ions indicative of MA analysis were able to be covertly
detected, when the MS system was mounted in the rear of a car [18]. Ion mobility spectroscopy (IMS)
has also been used as a screening tool during clandestine laboratory remediation to assess the level of
MA present in common building materials [19]. However, these methods of VOC analysis often rely
on laboratory-based detection techniques. Additionally, many different detection methods require
samples to be in the liquid phase for analysis. A method that extracts VOCs directly from a liquid
would reduce preparation times, need for specialised equipment and allow VOCs to be analysed by a
greater range of forensic instrumentation. A technique that is capable of onsite VOC collection and
detection would allow law enforcement agencies to rapidly assess potentially hazardous conditions
and aid investigators in analysing VOCs in laboratories. One potential method for onsite detection is
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the use of biosensors that are capable of detecting targets in the liquid phase, and thus, a system that
collects VOCs from a liquid substrate could be a potential method of onsite analysis [20,21].
A microfluidic gas-to-liquid (GTL) interface that uses an open capillary bed as a method of VOC
capture has recently been developed [22]. The GTL interface dispersed 30 µL of a liquid capture
agent throughout a microfluidic channel network. The microfluidic network significantly increased
the surface area of the liquid, so that, when a gas sample containing VOCs was pumped through the
interface, there was a rapid exchange of VOCs from the gas phase to the liquid phase. The liquid could
then be taken and analysed using conventional detection equipment that required solution-based
samples. In an initial study to characterise the GTL interface and the factors affecting the extraction
efficiency, allyl methyl sulfide and hexanal were extracted through the interface. It was found that the
extraction efficiency varied significantly depending on VOC type, input amount and concentration.
It was also found that decreasing the interface temperature to 15 ◦C during sampling and introducing a
lipophilic binding agent such as α-cyclodextrin (α-CD) increased extraction efficiency for compounds
with low water solubility. Under optimal conditions, the microfluidic GTL interface exhibited extraction
efficiencies of 3.7% and 30% for allyl methyl sulfide and hexanal, respectively [22]. It is hypothesised
that such a microfluidic device could be capable of extracting volatile ATS in gas samples. In this study,
we examined the efficacy of using this GTL interface as a screening tool for the extraction of ATS and the
related precursors from vapour-phase samples. If the GTL interface is found to be an effective method of
volatile ATS extraction, it has the potential to be used for clandestine laboratory investigation. The GTL
interface was characterised in terms of the presence/absence of the target compounds, extraction
efficiency (percentage yield) and extraction reproducibility from laboratory-prepared gas samples.
2. Materials and Methods
2.1. Microfluidic GTL Interface
The GTL interface was a three-layered borosilicate glass chip that allowed for the rapid exchange
of VOCs from the gas phase to the liquid phase [22] (Figure 1). The external dimensions of the interface
were 65 mm × 30 mm × 3.3 mm. Layer 1 was the base of the GTL interface and incorporated a repeating
tessellation of hexagonal protrusions with a size of 104 µm × 277 µm in a glass that formed an open
capillary bed. These channels, when saturated, could hold 30 µL of a liquid capture medium and
produce a gas contact area of approximately 3 cm2. Layer 2 was the gas chamber of the interface
holding approximately 500 µL of gas. Layer 3 was the seal to the GTL interface and included liquid
input and output wells for liquid priming and collection, in addition to two circular ports, which
were approximately 4 mm in diameter, for introducing gas samples [22]. Gas extraction was achieved
by pumping an air sample containing VOCs through the sealed microfluidic channel system via gas
ports. The VOCs from the air sample were transferred into the liquid capture medium and, following
extraction, were collected from the liquid output well using a syringe.
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Figure 1. (a) Cross-section of a gas-to-liquid (GTL) interface showing 3 bonded layers. (b) Photo of 
the GTL interface with a solution of red food colouring dispersed throughout capillary channels, 
liquid ports (LPs) and gas ports (GPs). (c) Overhead image of hexagonal protrusions that form the 
capillary network. (d) Depth profile showing hexagonal protrusions beneath the red line (top) and 3D 
image (bottom) of the hexagonal protrusion network. 
2.2. GTL Extraction Mounts 
A prototype mount was used for preliminary testing that optimised the extraction conditions 
identified during the initial characterisation study [22]. This mount consisted of a temperature 
controller connected to a thermal bed that the interface was inserted into for gas extraction. The 
thermal bed was set to 15 °C to work as a cold-trap, as this temperature was found to produce the 
highest extraction efficiency during the initial testing of the GTL interface. The prototype mount 
required manual flushing, cleaning, injection and collection of liquid from the interface, conducted 
using volumetric pipettes and gas-tight syringes. 
Grey Innovation (Melbourne, Australia) was tasked with designing an alternative interface 
mount that combined the functional elements of the prototype mount with the requirements for the 
pumping of gas and liquid through the interface. The developed product was a mount that replaced 
the manual flushing and priming of the microfluidic network with a pump, automating this part of 
the process (Figure 2). The thermal bed was also mounted on a camera pivot to maintain an 
appropriate angle during liquid collection at the end of the extraction process. The mount also 
replaced the sealing procedure used in the prototype with a saddle that sealed the interface shut with 
magnets, O-rings and septa. The saddle sat over the GTL interface and, when placed on top, sealed 
the liquid ports and replaced the septa used for sealing the gas ports with O-rings that led to luer 
locks, where syringe barrels could be attached (Figure 2b). The product was a mount that replaced 
the manual requirements of the prototype system with automated flushing, air-tight interface sealing 
and gravity feed systems. The Grey Innovation mount automated numerous manual handling steps, 
without intrinsically affecting the operation of the interface. The GTL interface priming, extraction 
and collection using the Grey Innovation mount are further outlined in Section 2.4.  
Figure 1. (a) Cross-section of a gas-to-liquid (GTL) interface showing 3 bonded layers. (b) Photo of the
GTL interface with a solution of red food colouring dispersed throughout capillary channels, liquid
ports (LPs) and gas ports (GPs). (c) Overhead image of hexagonal protrusions that form the capillary
network. (d) Depth profile showing hexagonal protrusions beneath the red line (top) and 3D image
(bottom) of the hexagonal protrusion network.
2.2. GTL Extraction Mounts
A prototype mount was used for preliminary testing that optimised the extraction conditions
identified during the initi l characterisation study [22]. This mount consisted of a temperature
controller connected to a thermal bed that the interface was inserted into for gas extraction. The thermal
bed was set to 15 ◦C t work as a col -tr p, as this temper ture was found to produce the highest
extraction efficiency during the initial testing of the GTL int rface. Th prototype m unt required
manual flushing, cleani g, injection and collection of liquid from the interface, conducted usi g
vol metric pipettes and as-tight syri ges.
Grey Innovation (Melbourne, Australia) was tasked with designing an alternative interface mount
that combined the fu ctional elements of the prototype mount with the requirements for the pumping
of gas and liquid through the interface. The developed pr duct was a mount t at replaced the manual
fl shing and priming of the microfluidic network with a pump, automating this part of the process
(Figure 2). The thermal bed was also mounted on a camera pivot to maintain an appropriate angle
during liquid collection at the end of the extraction pr cess. The mount also replaced the sealing
procedure used in the prototype with a saddle that sealed the interface shut with magnets, O-ri gs and
se ta. The saddle sat ver the GTL interface and, when place on top, sealed the liquid ports and
replaced the septa used for sealing the gas ports with O-rings that le to luer locks, where syringe
barrels could be attached (Figure 2b). The product was a mount that replaced the manual requirements
of the prototype system with automated flushing, air-tight interface sealing and gravity feed systems.
The Grey Innovation mount automated numerous manual handling steps, without intri sically affecti g
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the operation of the interface. The GTL interface priming, extraction and collection using the Grey
Innovation mount are further outlined in Section 2.4.Micromachi es 2020, 11, x 5 of 13 
 
 
Figure 2. Grey Innovation GTL interface mount: (a) overhead view showing a thermal bed (TB), a 
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employed in this study were purchased at 99% purity from the National Measurement Institute (West 
Lindfield, Australia). MA, N-formylmethamphetamine (FMA) and ephedrine were ordered as HCl 
salts that were subsequently converted to the free-base form and used to prepare 1000 ppm solutions 
in dichloromethane (DCM). Both dimethylamphetamine (DMA) and pseudoephedrine were 
purchased in the free-base form, and benzaldehyde and phenyl-2-propanone (P2P) were each 
prepared as 1000 ppm solutions in DCM. 
To generate each ATS/precursor gas sample, an aliquot of the 1000 ppm solution in DCM was 
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the RBF. The pump was positioned between the nitrogen source and the RBF to prevent pump 
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An alternative method of gas generation and storage was also tested using gas canisters to 
determine if different methods of storage or gas collection would affect the measured efficiency of 
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with the interior walls having a silanol coating to prevent VOCs from binding to the surface. To 
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was then pressurised with zero air and left for 24 h to reach equilibrium. The concentration was 
determined using the following equation [23]: 
Figure 2. t: (a) overhead view showing a thermal bed (TB),
a transparent saddle (TS), a pu ( ) ); ( ) tr s arent saddle with a
syringe bar el at ached; and (c) microfluidic GTL interface mounted on the thermal bed.
2.3. ATS Vapour Generation
Seven compounds were selected, as they represented common ATS on Australia’s drug market
and the most common precursors, from which they are synthesised. All ATS and precursors employed
in this study were purchased at 99% purity from the National Measurement Institute (West Lindfield,
Australia). MA, N-formylmethamphetamine (FMA) and ephedrine were ordered as HCl salts that
were subsequently converted to the free-base form and used to prepare 1000 ppm solutions in
dichloromethane (DCM). Both dimethylamphetamine (DMA) and pseudoephedrine were purchased in
the free-base form, and benzaldehyde and phenyl-2-propanone (P2P) were each prepared as 1000 ppm
solutions in DCM.
To generate each ATS/precursor gas sample, an aliquot of the 1000 ppm solution in DCM was
added to a 10 mL round-bottom flask (RBF), and the solvent was evaporated under a stream of nitrogen.
The RBF was then sealed with a septum and heated in a bath of glass beads to the boiling point of
each compound. When the glass-bead bath reached the boiling point, a nitrogen source regulated
by a flow-controlled pump (SKC, Dorest, England) was pierced through the septum in the RBF via
polytetrafluroethylene (PTFE) tubing fitted to a syringe. A 3 L Tedlar® bag (AES, Auburn, Australia)
filled with 2.5 L of nitrogen fitted with a syringe was also pierced through the septum in the RBF.
The pump was positioned between the nitrogen source and the RBF to prevent pump contamination.
Nitrogen at a flow rate of 50 mL/min was then pumped for 10 min (total 500 mL) from the source
through the RBF containing the gaseous ATS/precursor to the Tedlar® bag. The gaseous concentration
in ppmV was determined using the following equation:
S
106 LATSgas
Ltotal
(1)
where LATS gas(L of ATS as a gas) = nATS(mol of ATS) × 22.4 (molar volume constant).
When the vaporisation and the nitrogen dilution were complete, the Tedlar® bag was connected
to the GTL interface for microfluidic interface extraction.
An alternative method of gas generation and storage was also tested using gas canisters to
determine if different methods of storage or gas collection would affect the measured efficiency of the
GTL interface. These gas canisters were 6 L canisters designed for air analysis GCMS (AA-GCMS),
with the interior walls having a silanol coating to prevent VOCs from binding to the surface. To prepare
gas samples in the gas canisters, each target compound was vaporised in the same manner as above,
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but 10 mL of the gas from the RBF was drawn out using a syringe. This volume of the sample was
injected into a tee-piece fitted with a septum under a flow of zero air fed to a canister, which was under
vacuum. This resulted in the sample being drawn into the canister. The canister was then pressurised
with zero air and left for 24 h to reach equilibrium. The concentration was determined using the
following equation [23]:
Cws =
Vss×Css× 14.7
6× P (2)
where Cws is the concentration of the working standard (ppbV), Vss is the volume of the stock standard
injected (mL), Css is the concentration of the stock standard (ppmV), 14.7 is the value of 1 atmosphere
pressure (psia), 6 is the canister volume (L), and P is the pressure (psia).
In order to regulate the flow from the canister through the GTL interface, gas was siphoned out into
a Tedlar® bag, where the flow could be controlled with the pump specified earlier. As the effectiveness
of the GTL unit in extracting ATS from the vapour phase was unknown, high concentrations of ATS
were used during testing.
2.4. Sampling and Vapour Extraction
Prior to each use, the GTL interface was checked for water wettability by injecting 15 µL of an
aqueous solution of red food colouring in Milli-Q water into microfluidic channels. If the dye ran
smoothly through the microfluidic channels, then the channels had sufficient wettability. If the dye
did not run smoothly, then the GTL interface was submerged in a 1 M solution of NaOH overnight to
generate –OH groups on the glass surface to increase wettability [22]. To operate the GTL interface in
the prototype mount, the GTL interface was placed on the thermal bed that was coated with a layer of
oil to ensure good thermal contact. The temperature of the thermal bed was set to 15 ◦C. Septa were
attached to the gas ports using a double-sided adhesive tape and further held in place by wrapping the
tape around the GTL interface and the mount (Figure 3a). This was to ensure a gas-tight seal during
extraction. Once mounted, the interface was cleaned by flushing with repeated 15 µL aliquots of
Milli-Q water. It was then loaded with 3 × 15 µL aliquots of the 100 mM α-CD (Sigma-Aldrich, Castle
Hill, Australia) solution in Milli-Q water. α-CD was used as a capture agent to assist in the extraction
of highly hydrophobic compounds into an aqueous medium and showed a 10-fold improvement in
extraction during the initial method development [22,24]. The mount was held at a 15◦ angle to gravity
feed the solution to the liquid output port, where any excess solution could be collected and discarded,
leaving 30 µL within the capillary bed. An excess volume of solution was used to ensure that the liquid
in the capillary bed was solely composed of the α-CD solution and not the Milli-Q water from the
flushing step. The liquid ports were sealed with a Kapton tape, and syringes were pierced through
the septa into the gas inlet and outlet ports. The gas input syringe was connected to the Tedlar® bag
containing the target compound gas sample, and the output was connected to a pump that drew the
gas from the bag and through the interface. The gas was extracted through the interface for 6 min
at 50 mL/min (i.e., a total sampling volume of 300 mL). During extraction, the GTL interface and the
mount were kept level to prevent the spillage of the extracted liquid. Following extraction, the gas
input and output syringes and the tape were removed from the liquid ports, and 2 × 15 µL aliquots
of Milli-Q water were injected into the liquid input port and the mount held at an angle to gravity
feed the 30 µL of the α-CD solution, containing the extracted target compound, to the liquid output
port, where it was collected with a gas-tight syringe and transferred to a GC vial. This extraction was
repeated 7 times using the same Tedlar® bag gas sample (2.1 L of gas was consumed in total, and the
results were averaged). A bag containing pure nitrogen was also analysed as a control. The 30 µL
extractions each underwent liquid–liquid extraction (LLE) by adding 100 µL of DCM and agitating
for 1 min, after which excess sodium sulfate was added and agitated for 1 min to remove the water
layer. The DCM layer was collected in a GCMS vial fitted with a 150 µL vial insert (Agilent, Mulgrave,
Australia), and the extract was subjected to GCMS analysis.
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Figure 3. GTL extraction configuration of amphetamine-type substances (ATS) vapour: (a) prototype
GTL mount showing the GTL interface in the thermal bed (TB) and fitted with septa (SE), syringes
(SY), a pump (P) and a temperature controller (TC); and (b) Grey Innovation GTL mount showing the
GTL Interface in the thermal bed (TB) fitted with a transparent saddle (TS), syringe barrels (SB) and a
Tedlar® bag (TED) containing a gas sample.
The extraction procedure using the Grey Innovation mount followed the process used for the
prototype configuration but with automated steps replacing several manual handling steps in an
attempt to improve the GTL interface efficiency and repeatability. The microfluidic GTL interface was
placed on the thermal bed that was coated with a thin layer of oil, the interface was clamped down with
small arms (Figure 2c), and the temperature was set to 15 ◦C. The same order of flushing and priming
was then performed, but manual pipetting was replaced with an in-built pump that dispensed 15 µL
of the solution at a time. Manually tilting the GTL interface was replaced with a camera pivot that the
thermal bed was mounted on, so the same angle could be achieved for each extraction. Gas extraction
occurred under identical conditions to those used for the prototype mount. Thirty millilitres of the
α-CD solution containing the extracted target compound was collected in a similar manner, but the
water used to flush out the capture solution was pumped in rather than by using a pipette. The LLE of
each extraction aliquot remained unchanged (Figure 3b).
2.5. Instrument Parameters
The GCMS instrument parameters were based on the method used by the Forensic and Analytical
Science Service (FASS, NSW Health Pathology, New South Wales, Australia) for the analysis of Schedule
8 drugs. Samples were analysed on a Shimadzu GC-2010 Plus Capillary GC fitted with a Shimadzu
GCMS-QP2010 Ultra MS and a Shimadzu AOC-20i Auto Injector (Shimadzu, Kyoto, Japan). One
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microlitre of each sample was injected in the splitless mode into a 25 mm tapered liner (SGE Analytical,
Ringwood, Australia). A Rxi-5ms (length × internal diameter × column: 30 m × 0.25 mm × 0.25 µm;
Restek) was used for chromatographic separation with helium as a carrier gas set at a flow rate of
1 mL/min. Oven ramp conditions were as follows: initial temperature set at 50 ◦C held for 3 min,
increased at a ramp rate of 10 ◦C/min to 200 ◦C and then at a ramp rate of 15 ◦C/min to 300 ◦C.
The transfer line temperature was held at 260 ◦C. The ion source and quadrupole temperatures were
set to 230 and 150 ◦C, respectively. The MS system was operated in the scan mode with a scan range
(m/z) between 35 and 600 amu. Peak integration and identification were conducted using Shimadzu
GCMSolution Version 4.20 and the NIST Mass Spectral Library (2008). Peak areas were determined
via the extracted ion chromatograms for the base peak of each compound: benzaldehyde (106 m/z),
P2P (43 m/z), ephedrine (58 m/z), pseudoephedrine (58 m/z), MA (58 m/z), DMA (72 m/z) and NFMA
(86 m/z). In the case of ephedrine and pseudoephedrine, they were discriminated by comparison of
retention times to standards. The concentrations of ATS were determined by taking the peak areas of
the GTL aliquots and plotting them against their respective calibration curves. The mass yield was
calculated by converting the calculated concentration (mg/L) into the mass (µg/100 µL) in the DCM
extraction. The mass in the GTL aliquot was then divided by the calculated mass of ATS within the
Tedlar® bag to determine the yield (%) by mass.
3. Results
This study aimed to determine the efficiency and effectiveness of a microfluidic GTL interface
for the extraction of ATS and precursors from gas samples to an aqueous solution that could then
be analysed using traditional forensic techniques. Of the seven compounds tested in this research,
four were able to be detected when prepared as vapour samples in a Tedlar® bag and immediately
extracted through the GTL interface (Table 1).
Table 1. GTL extraction of ATS and precursors using the prototype mount.
Target Compound
ATS as
Vapour
(µg)1
ATS
Recovered
(µg)
Concentration
of GTL
Extractions
(µg mL–1)
Average
Yield (%)
RSD of
Replicates
(%)
Vapour Pressure
(mmHg at 25 ◦C)
[25–29]
GCMS
LOD
(µg mL–1)
Benzaldehyde 100 5.2 52 5.2 31.4 1.2 5.05
Phenyl-2-propanone 40 3.6 36 9.1 26.2 0.2 2.4
Methamphetamine 140 1.9 19 1.3 45.6 0.005 3.1
Dimethamphetamine 140 2.1 21 1.5 42.4 Data Notavailable 5.5
N-formylmethamphetamine 120 0.05 0.5 0.04 15.8 Data Notavailable 3.1
Ephedrine 100 Notdetected - - 0.001 6.9
Pseudoephedrine 100 Notdetected - - 0.0008 1.8
1 Maximum amount theoretically possible in a 300 mL sampling volume of the four compounds that were detected
in the GTL extract.
It can be seen from Table 1 that benzaldehyde and P2P had the greatest efficiency (defined as the
mass of the compound collected in the extract divided by the calculated mass of the compound in the
vapour sample), yielding 5.2% and 9.1%, respectively. MA and DMA behaved similarly, extracting
1.3%–1.5% of the ATS from the gas phase, and both displayed similar degrees of variance. The higher
variance than those of all the other detected compounds is likely due to the lower vapour pressures of
MA and DMA compared to those of the other three target compounds. FMA produced an extraction
efficiency of <1% despite the similar structure and physical properties to those of MA and DMA.
A duplicate Teldar® bag was prepared with FMA and extracted, which confirmed the initial result
as it produced a similar yield. The concertation of FMA in the GTL extract fell below the limit
of detection (LOD), and although EIC exhibited visible peaks with the characteristic ions of FMA,
its presence could not be confirmed or quantified with certainty. Viewing the data as a whole, none of
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the compounds displayed good repeatability when extracted through the GTL interface, producing
relative standard deviation (RSD) values above 15%. The high variance among all compounds is likely
a result of analysing low concentrations of nonvolatile compounds in the gas phase and difficulty with
regimenting a vaporisation process that could be kept constant throughout the entire study. Ephedrine
and pseudoephedrine were unable to be detected in any extraction. This finding is likely attributed
to the extremely low vapour pressure of both ephedrine and pseudoephedrine, causing the VOCs to
rapidly condense on any surfaces after vaporisation. A major limitation with this method of VOC
vapour generation and extraction is that if a compound has a low vapour pressure then it will rapidly
condense on cool (room temperature) surfaces post vaporisation, therefore resulting in negligible
amounts in the gas phase for extraction through the GTL interface. It is important to note that the
extraction efficiencies of the GTL interface were based off the assumed starting concentration in the
bag, calculated from the volume of ATS initially used during sample vaporisation. In reality, the ATS
concentration would likely be much less, as the ATS may not completely vaporise or may condense on
any material such as tubing or bags that are at ambient temperature. The extraction yield of the GTL
interface is therefore likely higher than those obtained.
Table 2 presents the data that were obtained when extractions were performed with the GTL
interface fitted to the Grey Innovation mount. Two Teldar® bags containing benzaldehyde and two
bags containing P2P were prepared and extracted to determine if the automated aspects of this mount
had any significant impact on the VOC extraction efficiency.
Table 2. GTL extraction of ATS and precursors using the Grey Innovation mount.
Compound
ATS as
Vapour
(µg)
ATS
Recovered
(µg)
Concentration of
GTL Extractions
(µg mL–1)
Yield (%)
RSD of
Replicates
(%)
Benzaldehyde (1) 100 2 20 2.0 28.0
Benzaldehyde (2) 100 4 40 3.7 48.9
Phenyl-2-propanone (1) 40 0.6 6 1.6 34.3
Phenyl-2-propanone (2) 40 0.6 6 1.6 25.4
These results, when compared to those obtained using the prototype mount, showed that the
Grey Innovation mount produced similar results for benzaldehyde. The benzaldehyde replicates were
within a similar range as for the previous tests, given the high variance observed. In contrast with the
previous results, the yield of P2P dropped significantly from 9.1% to 1.6%. The extraction efficiency of
P2P when conducted using the Grey Innovation mount was more in line with the results seen for every
other compound tested. Due to the extreme variance that was exhibited by all compounds, it was
argued that the P2P result from the prototype mount producing a higher extraction efficiency was a
result of the uncontrollable variables involved with sample vaporisation and that outlier results such
as the P2P yield in Table 1 may not be uncommon. Repeated sample generation procedures using the
same compound and volume generated under identical conditions may yield very different vapour
concentrations within a Tedlar® bag and hence different extraction efficiencies. Due to this reason,
the method of sample vaporisation had a profound impact on extraction efficiency and if a method
was used that could more precisely vaporise ATS, the variance exhibited by the GTL interface could
more accurately be determined. Further studies are required across a wider range of compounds
to determine if the Grey Innovation mount is beneficial in terms of the GTL extraction efficiency.
As it stands, any potential positive or negative effect is being masked by the high variance exhibited by
the method overall, regardless of which mount is employed. Aside from the analytical data, the Grey
Innovation mount was found to improve the ergonomics of the extraction procedure by automating
several manual handling steps. The new mount design also improved leak detection. This was due to
the automation reducing the number of tubing connections and syringes. Moreover, fewer connections
in this design needed to be checked to find the leak.
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Combining both experiments, conducted on both the original prototype and Grey Innovation
mounts, it can be seen that the GTL interface is capable of extracting target ATS and precursors from
the gas phase to an aqueous solution for subsequent detection by GCMS. However, due to the high
variance observed throughout the study, the results would not be suitable for quantification purposes.
Four of the seven target compounds were able to be detected at low concentrations in small (300 mL)
gas samples. This demonstrated that a GTL interface could be used as a screening tool for ATS and
their precursors in the vapour phase.
3.1. GTL Interface Sampling in Gas Canisters
An alternative gas storage method was investigated using specialised gas canisters for air analysis
to determine if it had an effect on the efficiency of extracting ATS using a microfluidic GTL interface.
Of the seven compounds investigated, only benzaldehyde was able to be detected when prepared in a
gas canister. A single canister was tested on two subsequent days to determine if similar extraction
efficiencies could be obtained and to determine the sampling variance and variance between days
(Table 3). Seven replicate extractions were conducted using the gas prepared in the canisters.
Table 3. GTL extraction of benzaldehyde in gas canisters using the prototype mount.
Compound ATS as Vapour(µg)
ATS
Recovered (µg)
Concentration of GTL
Extractions (µg mL–1) Yield (%)
RSD of
Replicates (%)
Benzaldehyde
at day 1 30 0.3 3 0.1 28.6
Benzaldehyde
at day 2 30 0.02 0.2 0.05 18.8
The results of the GTL extractions in the gas canisters indicated that using canisters as a gas
preparation and storage vessel greatly reduced the perceived efficiency of the process from over 5%
seen when prepared directly into a Tedlar® bag to less than 1%. The concertation of benzaldehyde in
the GTL extract fell below the LOD, and although EIC exhibited visible peaks with the characteristic
ions of benzaldehyde, its presence could not be confirmed or quantified with certainty. Using a canister
also had minimal effect on improving the repeatability of the extraction process given the high RSD
observed across all tests. There are two possible explanations for this outcome. In the 24 h after the
canister was left to reach equilibrium, the gas inside cooled. Low-volatility compounds could condense
on the interior walls of the canister and be unavailable in the gas phase for extraction and analysis.
Alternatively, elevated pressure within the canister may cause the vapour pressure of benzaldehyde to
decrease, reducing the concentration of benzaldehyde in the gas phase.
It is clear that Tedlar® bags performed better than canisters in terms of the overall extraction
efficiency. It is important to note, however, that the higher extraction efficiencies seen in the Tedlar®
bags are a reflection of the gas storage system, not the GTL interface itself. Different gas storage
methods will change the concentration of the target compound in the gas sample that flows through
the interface. As such, the calculated efficiency will change but not the actual interface efficiency.
Therefore, it is important to investigate alternative gas storage methods. Evacuated gas canisters are an
easy method to collect large volumes of gas without the need for pumps or polymer bags, and these are
used routinely in air quality management. In addition to this, gas canisters also enable gas to be stored
over long periods of time, whereas Tedlar® bags should be used immediately as long storage times
increase the risk of VOCs leaking through the pores in the bags or condensing on the walls of the bags.
Canisters are also able to be cleaned and recycled, and hence they are cheaper compared to single-use
Tedlar® bags. There is still a place for the use of gas canisters for air sample collection at clandestine
laboratory scenes; however, this would be restricted to more volatile ATS, precursors and solvents.
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3.2. Methodology Limitations and Future Research
This research was conducted as part of the CYBERNOSE® Project that is researching the application
of next-generation chemosensory protein-based olfactory biosensors for the detection of VOCs [30].
Due to the overarching aims of the broader project, the methodology and assessment of a microfluidic
GTL interface was limited in scope. It was a requirement to determine the extraction efficiencies for
each of the seven compounds, of which the majority are semi- or nonvolatile. As such, analysing
them in the gas phase had inherent limitations and resulted in a high degree of variation, which was
expected and certainly observed. The choice of a liquid medium was also limited to water, despite
the low solubility of the target compounds in this medium, as the GTL extractions are to be used in
conjunction with biosensors that are only compatible with aqueous solutions. Compared with other
VOC collection and detection studies such as the dynamic SPME method, the GTL interface required
less gas, consuming only 300 mL, whereas the SPME method required 10 L. The GTL mass yields were
comparable to those of the SPME method, which was able to detect ATS when their concentrations of
>40 µg were present [15]. The CME method outperformed the GTL method and was more sensitive,
but it did require larger volumes of gas [16]. The GTL interface using a liquid capture system does
allow for the GTL extractions to be analysed by a broader range of forensic instrumentation. Although
the extraction yields are low, emerging biosensor technology has the potential to be more sensitive
than a GCMS system. If biosensors are sufficiently sensitive at these concentrations, then the low
yields obtained may not be an issue. In addition, the aim of the project was to investigate the use of a
GTL interface to screen for ATS and their precursors in the vapour phase. If the GTL interface can
extract sufficient materials for biosensors to detect, then the GTL interface will work for its intended
screening purpose. As this microfluidic technology is still in its infancy, many of the aspects that may
affect extraction efficiency using a GTL interface are largely unknown. Factors such as capture agent
composition and concentration, use of high flow pumps and extraction competition between different
VOCs in the gas phase may have a large impact on extraction efficiency and need to be tested in depth.
Further use of a GTL interface, focusing on more volatile precursors and reagents (including solvents)
used in ATS manufacturing, may yield more successful results. In addition to this, the application of
this device is not limited in scope to drug detection but also general air quality control, environmental
management, food safety and other forensic applications such as explosives detection. We see this
study as a starting point for the investigation of a broader range of potential applications.
4. Conclusions
A new microfluidic GTL interface was tested to determine its efficiency and effectiveness in
extracting various ATS and their precursors out of the prepared vapour samples to a liquid medium
(aqueous solution). The GTL interface was able to extract benzaldehyde, P2P, MA, DMA and FMA out
of the prepared gas samples with a calculated 1%–10% extraction efficiency range, on average, based
on an assumed starting concentration. These extractions were able to be conducted for 6 min using a
300 mL gas sample, showing that the microfluidic GTL interface has potential for use as a screening
tool for the extraction of ATS and their precursors. However, due to the low volatility of the target
compounds tested in this study, a relatively large concentration may need to be present in the vapour
phase under ambient conditions to enable the extraction of a sufficient amount for traditional forensic
analysis using GCMS or ultra-performance liquid chromatography (UPLC). This new microfluidic
VOC capture technology is still in its infancy and requires further research to characterise its potential
uses, operational range and limitations; however, this research provides a framework for further
studies of this nature. With the level of customisation that is possible, including different capture
agents, high-flow pumps and portable detection equipment, there is a myriad of potential air analysis
applications. Provided that ATS and their precursors are present in sufficient concentrations in the gas
phase under ambient conditions, the microfluidic GTL interface could provide a rapid, cheap, sensitive
and robust alternative to conventional air sampling at clandestine laboratories
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